2010 |
| |
| University of Nottingham and ImmunoBiology Ltd (“ImmBio”) initiate Clostridium difficile Vaccine Programme, backed by the MRC
Tuesday 10th Aug 2010
[ more] |
| |
2008 |
| |
| ImmBio-Led Consortium Releases Promising Data for Meningitis B Vaccine
Friday 5th Sep 2008
[ more] |
| |
2007 |
| |
| ImmBio Additional Series C Funding Secured To Progress Its Product Portfolio
Tuesday 18th Sep 2007
[ more] |
| |
| |
| ImmunoBiology (ImmBio) Extend Its Collaboration With Eden Biodesign To Develop A New Generation Vaccine For Influenza
Wednesday 5th Sep 2007
[ more] |
| |
| |
| Eden Biodesign And ImmunoBiology (ImmBio) Develop Next Generation Vaccine For The Prevention Of Influenza
Tuesday 13th Mar 2007
[ more] |
| |
2006 |
| |
| ImmBio Therapeutics Secures EEDA Funding
Sunday 5th Nov 2006
[ more] |
| |
| |
| ImmBio Appoints Chairman and Non-Executive Directors
Friday 8th Sep 2006
[ more] |
| |
| |
| ImmBio and Scancell Announce Collaboration and Licensing of ImmunoBodies
Friday 30th Jun 2006
[ more] |
| |
| |
| ImmBio Executive Team Confirmed
Monday 23rd Jan 2006
[ more] |
| |
| |
| ImmunoBiology Ltd. is pleased to announce the closing of its Series C funding round.
Sunday 22nd Jan 2006
[ more] |
| |
2005 |
| |
| ImmunoBiology Ltd and Aeras Global TB Vaccine Foundation Conclude Novel TB Agreement
Monday 21st Nov 2005
[ more] |
| |
2004 |
| |
| Dr Chris Bailey appointed as Development Director.
Thursday 10th Jun 2004
[ more] |
| |
| |
| ImmunoBiology announces appointment of Alan Goodman as Chairman
Tuesday 24th Feb 2004
[ more] |
| |
2003 |
| |
| Avlar BioVentures invests in ImmunoBiology
Wednesday 12th Nov 2003
[ more] |
| |
| |
| ImmunoBiology Limited successfully raises £1million equity
Tuesday 10th Jun 2003
[ more] |
| |
2001 |
| |
| ImmBio wins a SMART Development award from the DTI
Thursday 20th Sep 2001
[ more] |
| |
